Utilizing Theranostics & Quantitative Systems Pharmacology to Enhance Translatability of Pre-Targeted ADC Therapies
- Discussing the importance of QSP modeling to determine translation of ADC dosing paradigms between animal and human studies
- Leveraging theranostics to better determine efficacy and safety of ADCs in the clinic
- Using PDX models to explore relationships between antigen expression level and efficacy